The Efficiency of MSC in Refractory Crohn's Disease
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The investigators' preliminary study indicates that MSC is effective therapy in treating IBD.
But the standard treatment is still lacking and the effect is not stable in IBD patients.
This study is to explore the efficacy and standard strategy when using MSC in refractory IBD.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Sixth Affiliated Hospital, Sun Yat-sen University
Collaborators:
Nanfang Hospital of Southern Medical University Third Affiliated Hospital, Sun Yat-Sen University